Alternative glucose metabolism and glycolytic suppression after human TBI

人类 TBI 后的替代葡萄糖代谢和糖酵解抑制

基本信息

项目摘要

Despite normal or increased cerebral glucose delivery, we have documented that cerebral glucose metabolism, even though it exceeds the level required to match CMRO2, rarely rises to the supranormal levels that might be expected to allow hyperglycolysis to compensate for the injury-induced energy crisis. In fact, cerebral glucose uptake is generally suppressed, despite evidence of ongoing metabolic demand. This suggests that post-traumatic glycolysis may be suppressed. Furthermore, we and other investigators have recently demonstrated that beyond the first 12-24 hours following traumatic brain injury the brain does not release lactate, but most often takes up and apparently consumes it. This unexpected finding implies that the excess glucose uptake above that required to match oxygen uptake represents neither hyperglycolysis nor hypoxia-induced anaerobic glycolysis, but has an alternative metabolic fate. In line with this concept, recent clinical 13C-glucose studies in our ICU have demonstrated that a substantial fraction of post-traumatic cerebral glucose metabolism supports activation of the pentose phosphate pathway in TBI patients. Based on these findings, our central hypothesis is that the post-acute phase biochemical and physiological environment acts 1.) to suppress glycolysis; 2.) to redirect glucose to alternative metabolic fates; and 3.) to promote the metabolic consumption of lactate and possibly other "downstream" alternative fuels, which can bypass the glycolytic obstruction. Experiments and methods to address these questions will involve sampling blood, cerebral spinal fluid, and extracellular fluid to measure concentrations of glucose and related biochemical products. Patients and normal control subjects will be infused with 13C-labelled glucose and the metabolic fates of glucose determined. Additionally, patients will undergo an intravenous infusion of lactate to determine if the suppression of glycolysis can be bypassed. This concept represents a substantial departure from the prevailing post-injury metabolic paradigm, which is focused on ischemia/hypoxia, hyperglycolysis, and lactate overproduction. If confirmed, these concepts would influence metabolic/nutritional support in the ICU, and would have to be incorporated into the current clinical protocols for managing glucose infusions and insulin administration.
尽管大脑葡萄糖输送正常或增加,我们已经证明, 代谢,即使它超过了匹配CMRO 2所需的水平,很少上升到超正常水平, 这可能是预期允许糖酵解过度以补偿损伤引起的能量危机的水平。在 事实上,尽管有持续代谢需求的证据,脑葡萄糖摄取通常受到抑制。这 表明创伤后糖酵解可能受到抑制。此外,我们和其他调查人员 最近证明,在创伤性脑损伤后的第一个12-24小时内,大脑不会 释放乳酸,但大多数情况下会吸收并消耗它。这一意外发现意味着, 超过与氧摄取相匹配所需的过量葡萄糖摄取既不代表糖酵解过度 也不是缺氧诱导的无氧糖酵解,而是具有替代的代谢命运。根据这一概念, 最近在我们ICU的临床13 C-葡萄糖研究表明, 脑葡萄糖代谢支持TBI患者戊糖磷酸途径的激活。基于 根据这些发现,我们的中心假设是,急性期后的生化和生理 环境法1.)抑制糖酵解; 2.)将葡萄糖重定向到替代的代谢命运;以及3.)到 促进乳酸盐和可能的其他“下游”替代燃料的代谢消耗, 绕过糖酵解障碍。解决这些问题的实验和方法将涉及采样 血液、脑脊液和细胞外液,以测量葡萄糖和相关的 生化产品。患者和正常对照受试者将输注13 C标记的葡萄糖和 确定葡萄糖的代谢命运。此外,患者将接受乳酸盐静脉输注 以确定是否可以绕过糖酵解的抑制。这一概念代表了一个实质性的 偏离了主要的损伤后代谢范例,其集中于缺血/缺氧, 糖酵解过度和乳酸盐过量产生。如果得到证实,这些概念将影响 代谢/营养支持在ICU,并将纳入目前的临床协议 用于管理葡萄糖输注和胰岛素给药。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NEIL A. MARTIN其他文献

NEIL A. MARTIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NEIL A. MARTIN', 18)}}的其他基金

Cerebral Lactate Metabolism Following Human Traumatic Brain Injury
人类脑外伤后脑乳酸代谢
  • 批准号:
    7257760
  • 财政年份:
    2007
  • 资助金额:
    $ 27.03万
  • 项目类别:
Cerebral Lactate Metabolism Following Human Traumatic Brain Injury
人类脑外伤后脑乳酸代谢
  • 批准号:
    7391739
  • 财政年份:
    2007
  • 资助金额:
    $ 27.03万
  • 项目类别:
HEMORRHAGE EVACUATION EMPLOYING MR ENDOSCOPIC SURGERY TRIAL
采用 MR 内窥镜手术进行出血清除试验
  • 批准号:
    6824627
  • 财政年份:
    2003
  • 资助金额:
    $ 27.03万
  • 项目类别:
INCIDENCE/TIME COURSE/PATHOPHYSIOLOGY--POSTTRAUMATIC BRAIN INJURY HYPERGLYCOLYSIS
发病率/时间进程/病理生理学--创伤后脑损伤高糖酵解
  • 批准号:
    6335094
  • 财政年份:
    2000
  • 资助金额:
    $ 27.03万
  • 项目类别:
INCIDENCE/TIME COURSE/PATHOPHYSIOLOGY--POSTTRAUMATIC BRAIN INJURY HYPERGLYCOLYSIS
发病率/时间进程/病理生理学--创伤后脑损伤高糖酵解
  • 批准号:
    6205041
  • 财政年份:
    1999
  • 资助金额:
    $ 27.03万
  • 项目类别:
INCIDENCE/TIME COURSE/PATHOPHYSIOLOGY--POSTTRAUMATIC BRAIN INJURY HYPERGLYCOLYSIS
发病率/时间进程/病理生理学--创伤后脑损伤高糖酵解
  • 批准号:
    6216690
  • 财政年份:
    1999
  • 资助金额:
    $ 27.03万
  • 项目类别:
INCIDENCE/TIME COURSE/PATHOPHYSIOLOGY--POSTTRAUMATIC BRAIN INJURY HYPERGLYCOLYSIS
发病率/时间进程/病理生理学--创伤后脑损伤高糖酵解
  • 批准号:
    6112395
  • 财政年份:
    1998
  • 资助金额:
    $ 27.03万
  • 项目类别:
HEMORRHAGE EVACUATION EMPLOYING MR ENDOSCOPIC SURGERY TRIAL
采用 MR 内窥镜手术进行出血清除试验
  • 批准号:
    7553863
  • 财政年份:
  • 资助金额:
    $ 27.03万
  • 项目类别:
Alternative glucose metabolism and glycolytic suppression after human TBI
人类 TBI 后的替代葡萄糖代谢和糖酵解抑制
  • 批准号:
    8043505
  • 财政年份:
  • 资助金额:
    $ 27.03万
  • 项目类别:
HEMORRHAGE EVACUATION EMPLOYING MR ENDOSCOPIC SURGERY TRIAL
采用 MR 内窥镜手术进行出血清除试验
  • 批准号:
    7553847
  • 财政年份:
  • 资助金额:
    $ 27.03万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 27.03万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.03万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 27.03万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.03万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 27.03万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 27.03万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.03万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 27.03万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 27.03万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 27.03万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了